Because of a change in manufacturing and rebranding, the syringes have different dimensions and were made by a new contract manufacturer.
“The dimensional changes made to the Cardinal Health Monoject syringes, when used with syringe pumps, PCA pumps or enteral syringe pumps, may result in recognition, compatibility, and pump performance issues, such as overdose, underdose, delay in therapy, delay in occlusion alarms, and delay in feeding,” the FDA said.
The latest update reports there have been zero deaths reported, but it does not mention any other adverse events.
In late 2023, the FDA opened an investigation into China-made plastic syringes because of reports of incompatibilities, with products breaking and leaking.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.